Cargando…
Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future
Glioblastoma is the most common primary malignant tumor in the brain and has a dismal prognosis despite patients accepting standard therapies. Alternation of genes and deregulation of proteins, such as receptor tyrosine kinase, PI3K/Akt, PKC, Ras/Raf/MEK, histone deacetylases, poly (ADP-ribose) poly...
Autores principales: | Huang, Wenda, Hao, Zhaonian, Mao, Feng, Guo, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247310/ https://www.ncbi.nlm.nih.gov/pubmed/35785151 http://dx.doi.org/10.3389/fonc.2022.911876 |
Ejemplares similares
-
S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma
por: Huang, Wenda, et al.
Publicado: (2022) -
EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study
por: Hao, Zhaonian, et al.
Publicado: (2019) -
Ozone therapy for high-grade glioma: an overview
por: Yanchu, Li, et al.
Publicado: (2023) -
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017) -
Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)